Featured Article

Xylem Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD December 17, 2024

Xylem, a global water treatment company, had a positive Q3 2024. Revenue rose 1.3 % to $2.1 billion and earnings before interest and taxes rose 47% to $280 million over the same period last year. A review of Xylem’s 31 October 2024 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Mathew Pine, the CEO of Xylem since January this year, was proud of his team’s…

Read More

In This Issue

定價決策管理層與業務團隊在提高價格時的可能衝突與溝通磨合

By Yuhung S. Shen February 27, 2024

當企業在執行定價決策的時候,考慮到的首先是產品的價值,產品的價值減去定價就會是消費者能獲得的額外利益(消費者剩餘),當消費者可以獲得的額外利益越高的時候,消費者也就更傾向於購買產品而不是競爭對手的產品

Read More

Dover Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD January 16, 2024

Dover, a global manufacturer of industrial components for end-market industries, had a somewhat positive Q3 2023. Revenue was relatively unchanged at $2.1…

Read More

nVent Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD January 16, 2024

nVent, a provider of enclosures, electrical and fastening, and thermal management solutions, had a positive Q3 2023. Revenue rose 15% to $859…

Read More

Stanley Black & Decker Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD January 16, 2024

Stanley Black & Decker, a tools and hardware company, had a mixed Q3 2023. Revenue fell 4% to $3.95 billion but earnings…

Read More

WIGLAF, STRAIGHT
TO YOUR INBOX